How to Enhance Generic Drug Development Efficiency

The FDA is streamlining the generic drug development process to improve patient access to affordable medications. Measures include clarifying regulatory expectations, refining clinical trial designs, using real-world evidence and patient-reported outcomes, and utilizing funds from the Generic Drug User Fee program. These efforts not only benefit patients but also contribute to the long-term sustainability of the healthcare system.